PRE-DETERMINE Cohort Study

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01114269
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH), Abbott Medical Devices (Industry), Northwestern University (Other), Roche Diagnostics (Industry), Quintiles, Inc. (Industry)
5,764
90
183
64
0.3

Study Details

Study Description

Brief Summary

This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    5764 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
    Study Start Date :
    Jul 1, 2007
    Anticipated Primary Completion Date :
    Oct 1, 2022
    Anticipated Study Completion Date :
    Oct 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation. [Median follow-up estimated to be 8 years]

      A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation.

    Secondary Outcome Measures

    1. ICD Shock [Median follow-up estimated to be 8 years]

      ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint.

    2. ICD Implantation [Median follow-up estimated to be 8 years]

    3. Total Cardiac Mortality [Median follow-up estimated to be 8 years]

    4. Total Mortality [Median follow-up estimated to be 8 years]

    5. Non-Sudden or Arrhythmic Causes of Mortality [Median follow-up estimated to be 8 years]

      Competing causes of mortality in competing risk analyses.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.

    2. LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.

    3. If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.

    4. Patients aged 18 years or above

    5. CAD will be defined as evidence of one of the following two (2) criteria:

    • Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography

    • Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)

    1. MI can be documented in the following ways:
    • From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:

    • Symptoms of Ischemia

    • ECG changes indicative of new ischemia (new ST-T changes or new LBBB)

    • Development of pathological Q waves

    • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality

    • If no report from the MI hospitalization is available, prior MI can be met by either of the following:

    • Development of pathological Q waves

    • Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause

    Exclusion Criteria:
    1. History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).

    2. Unexplained syncope

    3. Current or planned implantable cardiac defibrillator (ICD)

    4. Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)

    5. Metastatic cancer

    6. Marked valvular heart disease requiring surgical intervention

    7. Current or planned cardiac, renal or liver transplant

    8. Current alcohol or drug abuse

    9. Unwilling or unable to provide informed consent

    10. LVEF <35% with Class II-IV CHF or LVEF <30%

    11. Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Alaska Heart Institute Anchorage Alaska United States 99508
    2 Phoenix Heart, PLLC Glendale Arizona United States 85306
    3 Cardiovascular Consultants Phoenix Arizona United States 85032
    4 Beaver Medical Group/Clinical Care Research Banning California United States 92220
    5 Memorial Health System Colorado Springs Colorado United States 80909
    6 Colorado Heart and Vascular Denver Colorado United States 80204
    7 Bay Area Cardiology Associates, P.A. Brandon Florida United States 33511
    8 University of Florida - Gainsville Gainesville Florida United States 32610
    9 Mount Sinai Medical Center Miami Beach Florida United States 33140
    10 Reliable Clinical Research Miami Florida United States 33135
    11 Florida Hospital Orlando Florida United States 32804
    12 Orlando Regional Medical Center Orlando Florida United States 32806
    13 Palm Beach Gardens Research Center Palm Beach Gardens Florida United States 33410
    14 Velella Research Sarasota Florida United States 34233
    15 Tallahassee Research Institute, Inc. Tallahassee Florida United States 32308
    16 Cardiology Associates of Palm Beach - West Palm Beach West Palm Beach Florida United States 33401
    17 Georgia Heart Specialist Covington Georgia United States 30014
    18 Northeast Georgia Heart Center, P.C. Gainesville Georgia United States 30501
    19 University of Chicago Chicago Illinois United States 60637
    20 Advocate Medical Group Chicago Illinois United States 60643
    21 Advocate Medical Group - Heart and Vascular of IL Chicago Illinois United States 60657
    22 Consultants in Cardiovascular Medicine Melrose Park Illinois United States 60160
    23 Community Heart and Vascular Anderson Indiana United States 46011
    24 Iowa Heart Center West Des Moines Iowa United States 50266
    25 The University of Kansas Kansas City Kansas United States 66160
    26 Baptist Health Lexington Lexington Kentucky United States 40503
    27 Leonard J. Chabert Medical Center Houma Louisiana United States 70363
    28 Maine Research Associates Auburn Maine United States 04210
    29 Maine Research Associates - Lewiston Lewiston Maine United States 04240
    30 University of Maryland Medical Center Baltimore Maryland United States 21201
    31 Primary Care Cardiology Research Ayer Massachusetts United States 01432
    32 Brigham and Women's Hospital Boston Massachusetts United States 02115
    33 NECCR Internal Medicine and Cardiology Associates, LLC Fall River Massachusetts United States 02720
    34 Hawthorn Medical Associates North Dartmouth Massachusetts United States 02747
    35 Baystate Cardiology Springfield Massachusetts United States 01199
    36 University of Michigan Medical Center Ann Arbor Michigan United States 48109
    37 Oakwood Hospital & Medical Center Dearborn Michigan United States 48124
    38 McLaren Medical Center - Macomb Mount Clemens Michigan United States 48043
    39 Michigan Heart Ypsilanti Michigan United States 48197
    40 Minneapolis VA Medical Center Minneapolis Minnesota United States 55417
    41 University of Missouri Health Care Columbia Missouri United States 65201
    42 Glacier View Cardiology Kalispell Montana United States 59901
    43 The Cardiac Center of Creighton University Omaha Nebraska United States 68131
    44 Advanced Heartcare, LLC Bridgewater New Jersey United States 08807
    45 St. Joseph Regional Medical Center Paterson New Jersey United States 07503
    46 New Mexico VA Healthcare Systems Albuquerque New Mexico United States 87108
    47 Albany Associates Cardiology Albany New York United States 12205
    48 Maimonides Medical Center Brooklyn New York United States 11219
    49 Buffalo General Hospital/Kaleida Health Buffalo New York United States 14203
    50 Jamaica Hospital Medical Center Jamaica New York United States 11418
    51 Mid-Valley Cardiology Kingston New York United States 12401
    52 Winthrop-University Hospital Mineola New York United States 11501
    53 Gotham Cardiovascular New York New York United States 10001
    54 Columbia University Health Center New York New York United States 10032
    55 Stony Brook University Medical Center Stony Brook New York United States 11794
    56 St. Elizabeth Medical Center - Hotvedt Utica New York United States 13501
    57 Asheville Cardiology Associates Asheville North Carolina United States 28801
    58 Eastern Carolina Cardiovascular Elizabeth City North Carolina United States 27909
    59 Northstate Clinical Research Lenoir North Carolina United States 28645
    60 Pinehurst Medical Clinic, Inc. Pinehurst North Carolina United States 28374
    61 Sanford Cardiology Sanford North Carolina United States 27330
    62 Wake Forest Winston-Salem North Carolina United States 27157
    63 Northeast Ohio Cardiovascular Specialists Akron Ohio United States 44304
    64 University of Cincinnati Cincinnati Ohio United States 45267
    65 MetroHealth Medical Center Cleveland Ohio United States 44109
    66 North Ohio Research, Ltd. Elyria Ohio United States 44035
    67 Mercy Medical Associates Fairfield Ohio United States 45014
    68 Northwest Ohio Cardiology Consultants/The Toledo Hospital Toledo Ohio United States 43615
    69 Oklahoma City VA Medical Center Veterans Research and Education Foundation Oklahoma City Oklahoma United States 73104
    70 Oklahoma Foundation for Cardiovascular Research Oklahoma City Oklahoma United States 73120
    71 Abington Memorial Hospital Abington Pennsylvania United States 19001
    72 St. Luke's Bethlehem Bethlehem Pennsylvania United States 18018
    73 Doylestown Cardiology Associates Doylestown Pennsylvania United States 18901
    74 Allegheny General Hospital Pittsburgh Pennsylvania United States 15212
    75 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States 15213
    76 AnMed Health Anderson South Carolina United States 29621
    77 VA Medical Center - Charleston Charleston South Carolina United States 29425
    78 Carolina Cardiology Associates Rock Hill South Carolina United States 29732
    79 Black Hills Cardiovascular Research Rapid City South Dakota United States 57701
    80 Cardiovasular Research of Knoxville Knoxville Tennessee United States 37917
    81 Memphis VA Medical Center Memphis Tennessee United States 38104
    82 St. Luke's Episcopal Hospital Houston Texas United States 77030
    83 Non-Invasive Cardiovascular PA Houston Texas United States 77074
    84 Providence Health Center Waco Texas United States 76712
    85 Intermountain Medical Center Murray Utah United States 84157
    86 Cardiovascular Associates Virginia Beach Virginia Beach Virginia United States 23454
    87 University of Alberta Edmonton Alberta Canada T6G 2B7
    88 Vancouver General Hospital Vancouver British Columbia Canada V5Z 1M9
    89 Mississauga Clinical Research Centre Mississauga Ontario Canada L5B 2P7
    90 Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe Rio Piedras Puerto Rico 00924

    Sponsors and Collaborators

    • Brigham and Women's Hospital
    • National Heart, Lung, and Blood Institute (NHLBI)
    • Abbott Medical Devices
    • Northwestern University
    • Roche Diagnostics
    • Quintiles, Inc.

    Investigators

    • Principal Investigator: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Christine M. Albert, MD, MPH, Principal Investigator, Brigham and Women's Hospital
    ClinicalTrials.gov Identifier:
    NCT01114269
    Other Study ID Numbers:
    • 2007P000840
    • R01HL091069
    First Posted:
    May 3, 2010
    Last Update Posted:
    Jul 22, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Christine M. Albert, MD, MPH, Principal Investigator, Brigham and Women's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 22, 2022